Characterization of cholecystokinin octapeptide-stimulated endogenous dopamine release from rat nucleus accumbens in vitro
- PMID: 2361176
- PMCID: PMC1917566
- DOI: 10.1111/j.1476-5381.1990.tb13018.x
Characterization of cholecystokinin octapeptide-stimulated endogenous dopamine release from rat nucleus accumbens in vitro
Abstract
1. The effect of cholecystokinin sulphated octapeptide (CCK8S) on endogenous dopamine release was examined in rat striatal and nucleus accumbens slices, by high performance liquid chromatography (h.p.l.c.) with electrochemical detection. 2. CCK8S was shown to increase dopamine release from slices of nucleus accumbens but not striatum in a dose-dependent manner between 0.1 and 10 microM. 3. Pentagastrin was without effect on dopamine release at doses up to 10 microM. 4. The dopamine release produced in the presence of CCK8S was abolished by preincubation of the slice with 1.0 or 10.0 nM L-364,718 (the CCKA-selective antagonist) while 1 microM L-365,260 (the CCKB-selective antagonist) had no action. 5. These results suggest that the CCK8S-evoked release of dopamine from the nucleus accumbens is mediated by a CCKA-receptor.
Similar articles
-
Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms.J Neurochem. 1991 Mar;56(3):917-22. doi: 10.1111/j.1471-4159.1991.tb02009.x. J Neurochem. 1991. PMID: 1993898
-
In vivo release of dopamine in the nucleus accumbens of the rat: modulation by cholecystokinin.Brain Res. 1984 Mar 26;296(1):189-93. doi: 10.1016/0006-8993(84)90531-6. Brain Res. 1984. PMID: 6324955
-
Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in nucleus accumbens of the rat via the CCK-B receptor.Brain Res. 1994 Sep 19;657(1-2):159-64. doi: 10.1016/0006-8993(94)90963-6. Brain Res. 1994. PMID: 7820614
-
Cholecystokinin/dopamine/GABA interactions in the nucleus accumbens: biochemical and functional correlates.Peptides. 2001 Aug;22(8):1229-34. doi: 10.1016/s0196-9781(01)00446-6. Peptides. 2001. PMID: 11457515 Review.
-
Cholecystokinin, dopamine, and schizophrenia: recent progress and current problems.Ann N Y Acad Sci. 1988;537:362-79. doi: 10.1111/j.1749-6632.1988.tb42120.x. Ann N Y Acad Sci. 1988. PMID: 3059932 Review. No abstract available.
Cited by
-
Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients.Psychopharmacology (Berl). 1994 Apr;114(3):449-55. doi: 10.1007/BF02249335. Psychopharmacology (Berl). 1994. PMID: 7855203 Clinical Trial.
-
Pharmacology of a cholecystokinin receptor on 5-hydroxytryptamine neurones in the dorsal raphe of the rat brain.Br J Pharmacol. 1991 Mar;102(3):635-8. doi: 10.1111/j.1476-5381.1991.tb12225.x. Br J Pharmacol. 1991. PMID: 1364831 Free PMC article.
-
Electrophysiological evidence for the implication of cholecystokinin in the modulation of the N-methyl-D-aspartate response by sigma ligands in the rat CA3 dorsal hippocampus.Naunyn Schmiedebergs Arch Pharmacol. 1996 Mar;353(4):382-90. doi: 10.1007/BF00261434. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8935704
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources